|
⚲
|
| Keyboard |
| Bain Capital Life Sciences Opportunities III LP
✚
|
|
|---|---|
| CIK # | 0001950105 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001950105] | |
| 3 | [0001950105] | |
| 4 | [0001950105] | |
| SC 13G | [0001950105] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Conversion | 2,713,868 | ||
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Buy | 450,000 | $22.00 | 9,900,000 |
|
Kyverna Therapeutics Inc KYTX
Series B Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 12,351,087 | $0.00 |